Omega Healthcare (0KBL) Share Forecast & Price Target

3 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0KBL Analyst Ratings

Hold

5 Buy

5 Hold

2 Sell

Based on 12 analysts giving stock ratings to

Omega

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0KBL Stock 12 Month Forecast

Average Price Target

$50.58

▲(8.36% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Omega Healthcare in the last 3 months. The average price target is $50.58 with a high forecast of $58.00 and a low forecast of $46.00. The average price target represents a 8.36% change from the last price of $46.68.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"38":"$38","59":"$59","43.25":"$43.3","48.5":"$48.5","53.75":"$53.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":58,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$58.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":50.583333333333336,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$50.58</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":46,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$46.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[38,43.25,48.5,53.75,59],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,45.42,46.38769230769231,47.355384615384615,48.323076923076925,49.29076923076923,50.25846153846154,51.22615384615385,52.19384615384615,53.16153846153846,54.12923076923077,55.096923076923076,56.06461538461539,57.03230769230769,{"y":58,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,45.42,45.81717948717949,46.21435897435897,46.611538461538466,47.00871794871795,47.40589743589744,47.80307692307692,48.200256410256415,48.5974358974359,48.994615384615386,49.39179487179487,49.788974358974365,50.18615384615385,{"y":50.583333333333336,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,45.42,45.464615384615385,45.50923076923077,45.55384615384615,45.59846153846154,45.643076923076926,45.68769230769231,45.73230769230769,45.776923076923076,45.82153846153846,45.86615384615385,45.91076923076923,45.95538461538462,{"y":46,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":39.851,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.806,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.921,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.671,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.569,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.87,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.913,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.171,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.298,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.631,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.48,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.68,"date":1788220800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":45.42,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$58.00

Average Price Target$50.58

Lowest Price Target$46.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Aaron Hecht

Citizens JMP

$52

Buy

11.40%

Upside

Upgraded

10/22/26

Omega Healthcare upgraded to Outperform from Market Perform at CitizensOmega Healthcare upgraded to Outperform from Market Perform at Citizens

John Kilichowski

Wells Fargo

$48→$46

Hold

-1.46%

Downside

Assigned

10/19/26

Omega Healthcare price target lowered to $46 from $48 at Wells FargoOmega Healthcare price target lowered to $46 from $48 at Wells Fargo

Michael Goldsmith

UBS

$54→$52

Buy

11.40%

Upside

Assigned

10/13/26

Omega Healthcare price target lowered to $52 from $54 at UBSOmega Healthcare price target lowered to $52 from $54 at UBS

Richard Hightower

Barclays

$50→$48

Sell

2.83%

Upside

Reiterated

10/13/26

Barclays Keeps Their Sell Rating on Omega Healthcare (OHI)

Dave Rodgers

Raymond James

$55→$53

Buy

13.54%

Upside

Reiterated

10/06/26

Omega Healthcare price target lowered to $53 from $55 at Raymond JamesOmega Healthcare price target lowered to $53 from $55 at Raymond James

Michael Carroll

RBC Capital

$51

Hold

9.25%

Upside

Reiterated

09/11/26

RBC Capital Keeps Their Hold Rating on Omega Healthcare (OHI)

Vikram Malhotra

Mizuho Securities

$45→$46

Hold

-1.46%

Downside

Reiterated

08/31/26

Omega Healthcare price target raised to $46 from $45 at MizuhoOmega Healthcare price target raised to $46 from $45 at Mizuho

Farrell Granath

Bank of America Securities

$49

Sell

4.97%

Upside

Reiterated

08/14/26

Analysts Offer Insights on Real Estate Companies: Omega Healthcare (NYSE: OHI) and GPT Group (Other OTC: GPTGF)

Michael Lewis

Truist Financial

$46→$47

Hold

0.69%

Upside

Reiterated

08/13/26

Analysts Offer Insights on Real Estate Companies: Uniti Group (NASDAQ: UNIT) and Omega Healthcare (NYSE: OHI)

Nicholas Joseph

Citi

$52→$58

Buy

24.25%

Upside

Reiterated

08/04/26

Citi Keeps Their Buy Rating on Omega Healthcare (OHI)

Richard Anderson

Cantor Fitzgerald

$52→$56

Buy

19.97%

Upside

Assigned

07/31/26

Analysts Offer Insights on Real Estate Companies: Omega Healthcare (NYSE: OHI), Broadstone Net Lease (NYSE: BNL) and Jones Lang Lasalle (NYSE: JLL)

Nicholas Yulico

Scotiabank

$47→$49

Hold

4.97%

Upside

Reiterated

07/31/26

Scotiabank Sticks to Its Hold Rating for Omega Healthcare (OHI)

Julien Blouin

Goldman Sachs

$59→$63

Buy

34.96%

Upside

Reiterated

06/02/26

Analysts Offer Insights on Real Estate Companies: Omega Healthcare (NYSE: OHI), Jones Lang Lasalle (NYSE: JLL) and Cushman & Wakefield (NYSE: CWK)

Juan C. Sanabria

BMO Capital

$32.7→$52

Hold

11.40%

Upside

Reiterated

05/03/26

BMO Capital Sticks to Their Hold Rating for Omega Healthcare (OHI)

Unknown Analyst

Berenberg Bank

Not Ranked

Berenberg Bank

$53

Buy

13.54%

Upside

Reiterated

02/20/26

Omega Healthcare (OHI) Receives a Buy from Berenberg Bank

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Aaron Hecht

Citizens JMP

$52

Buy

11.40%

Upside

Upgraded

10/22/26

Omega Healthcare upgraded to Outperform from Market Perform at CitizensOmega Healthcare upgraded to Outperform from Market Perform at Citizens

John Kilichowski

Wells Fargo

$48→$46

Hold

-1.46%

Downside

Assigned

10/19/26

Omega Healthcare price target lowered to $46 from $48 at Wells FargoOmega Healthcare price target lowered to $46 from $48 at Wells Fargo

Michael Goldsmith

UBS

$54→$52

Buy

11.40%

Upside

Assigned

10/13/26

Omega Healthcare price target lowered to $52 from $54 at UBSOmega Healthcare price target lowered to $52 from $54 at UBS

Richard Hightower

Barclays

$50→$48

Sell

2.83%

Upside

Reiterated

10/13/26

Barclays Keeps Their Sell Rating on Omega Healthcare (OHI)

Dave Rodgers

Raymond James

$55→$53

Buy

13.54%

Upside

Reiterated

10/06/26

Omega Healthcare price target lowered to $53 from $55 at Raymond JamesOmega Healthcare price target lowered to $53 from $55 at Raymond James

Michael Carroll

RBC Capital

$51

Hold

9.25%

Upside

Reiterated

09/11/26

RBC Capital Keeps Their Hold Rating on Omega Healthcare (OHI)

Vikram Malhotra

Mizuho Securities

$45→$46

Hold

-1.46%

Downside

Reiterated

08/31/26

Omega Healthcare price target raised to $46 from $45 at MizuhoOmega Healthcare price target raised to $46 from $45 at Mizuho

Farrell Granath

Bank of America Securities

$49

Sell

4.97%

Upside

Reiterated

08/14/26

Analysts Offer Insights on Real Estate Companies: Omega Healthcare (NYSE: OHI) and GPT Group (Other OTC: GPTGF)

Michael Lewis

Truist Financial

$46→$47

Hold

0.69%

Upside

Reiterated

08/13/26

Analysts Offer Insights on Real Estate Companies: Uniti Group (NASDAQ: UNIT) and Omega Healthcare (NYSE: OHI)

Nicholas Joseph

Citi

$52→$58

Buy

24.25%

Upside

Reiterated

08/04/26

Citi Keeps Their Buy Rating on Omega Healthcare (OHI)

Richard Anderson

Cantor Fitzgerald

$52→$56

Buy

19.97%

Upside

Assigned

07/31/26

Analysts Offer Insights on Real Estate Companies: Omega Healthcare (NYSE: OHI), Broadstone Net Lease (NYSE: BNL) and Jones Lang Lasalle (NYSE: JLL)

Nicholas Yulico

Scotiabank

$47→$49

Hold

4.97%

Upside

Reiterated

07/31/26

Scotiabank Sticks to Its Hold Rating for Omega Healthcare (OHI)

Julien Blouin

Goldman Sachs

$59→$63

Buy

34.96%

Upside

Reiterated

06/02/26

Analysts Offer Insights on Real Estate Companies: Omega Healthcare (NYSE: OHI), Jones Lang Lasalle (NYSE: JLL) and Cushman & Wakefield (NYSE: CWK)

Juan C. Sanabria

BMO Capital

$32.7→$52

Hold

11.40%

Upside

Reiterated

05/03/26

BMO Capital Sticks to Their Hold Rating for Omega Healthcare (OHI)

Unknown Analyst

Berenberg Bank

Not Ranked

Berenberg Bank

$53

Buy

13.54%

Upside

Reiterated

02/20/26

Omega Healthcare (OHI) Receives a Buy from Berenberg Bank

Stocks with the Highest Top Analyst Consensus in the Real Estate Sector

CBRECBRE Group

IRMIron Mountain

RHPRyman

AHRAmerican Healthcare REIT, Inc.

WELLWelltower

Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Omega Healthcare

3 Months

Nicholas JosephCiti

Success Rate

3/4 ratings generated profit

Average Return

+5.03%

Copying Nicholas Joseph's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +5.03% per trade.

1 Year

Dave RodgersRaymond James

Success Rate

3/3 ratings generated profit

Average Return

+6.93%

Copying Dave Rodgers's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.93% per trade.

2 Years

Dave RodgersRaymond James

Success Rate

3/3 ratings generated profit

Average Return

+6.93%

Copying Dave Rodgers's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +6.93% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0KBL Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0KBL has received 5 Buy Ratings, 6 Hold Ratings, and 3 Sell Ratings. 0KBL average Analyst price target in the past 3 months is 50.58.

Each month's total comprises the sum of three months' worth of ratings.

0KBL Financial Forecast

0KBL Earnings Forecast

Next quarter’s earnings estimate for 0KBL is $0.47 with a range of $0.44 to $0.50. The previous quarter’s EPS was $1.19. 0KBL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 54.52% of the time in the same period. In the last calendar year 0KBL has Performed in-line its overall industry.

0KBL Sales Forecast

Next quarter’s sales forecast for 0KBL is $269.16M with a range of $249.84M to $284.90M. The previous quarter’s sales results were $330.25M. 0KBL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 73.09% of the time in the same period. In the last calendar year 0KBL has Performed in-line its overall industry.

0KBL Stock Forecast FAQ

What is GB:0KBL’s average 12-month price target, according to analysts?

Based on analyst ratings, Omega Healthcare’s 12-month average price target is 50.58.

What is GB:0KBL’s upside potential, based on the analysts’ average price target?

Omega Healthcare has 8.36% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Omega Healthcare a Buy, Sell or Hold?

Omega Healthcare has a consensus rating of Hold, which is based on 5 buy ratings, 5 hold ratings and 2 sell ratings.

What is Omega Healthcare’s share price target?

The average share price target for Omega Healthcare is 50.58. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $58.00 ,and the lowest forecast is $46.00. The average share price target represents 8.36% Increase from the current price of $46.68.

What do analysts say about Omega Healthcare?

Omega Healthcare’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Omega Healthcare?

To buy shares of GB:0KBL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Omega Healthcare (0KBL) Share Forecast & Price Target

0KBL Analyst Ratings

0KBL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Omega Healthcare

0KBL Analyst Recommendation Trends

0KBL Financial Forecast

0KBL Earnings Forecast

0KBL Sales Forecast

0KBL Stock Forecast FAQ

Detailed List of Analyst Forecasts